International Journal of Drug Policy
Volume 18, Issue 2 , Pages 92-98 , March 2007

Coverage of HIV prevention programmes for injection drug users: Confusions, aspirations, definitions and ways forward

  • Mukta Sharma

      Affiliations

    • Department of Social Policy, London School of Economics, United Kingdom
    • Tel.: +880 1715286397; fax: +880 29887563.
    • ,
  • Dave Burrows

      Affiliations

    • AIDS Projects Management Group, Level 2, 50 York Street, Sydney, NSW 2000, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 2 8231 6625; fax: +61 2 8231 6624.
    • ,
  • Ricky Bluthenthal

      Affiliations

    • RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA 90407-2138, United States
    • Urban Community Research Centre, California State University Dominguez Hills, United States

Received 15 October 2006 ,Revised 26 November 2006 ,Accepted 27 November 2006.

References 

  1. Aceijas, C., Hickman, M., Donoghoe, M. C., Burrows, D., & Stuikyte, R. (2006). Access and coverage of needle and syringe programs (NSP) in Central and Eastern Europe and Central Asia, submitted for publication.
  2. Anderson RM, May RM. Immunisation and herd immunity. Lancet. 17 March 1990;335(8690):641–645
  3. APMG AIDS Projects Management Group. (2006). Proceedings of the APMG satellite session on coverage of harm reduction programs at the 17th international conference on the reduction of drug-related harm, Vancouver 2 May. Sydney/Geneva. Accessed on 12 September 2006: http://www.aidsprojects.com/uploads/pdf/76.pdf.
  4. Azim T, Hussein N, Kelly R. Effectiveness of harm reduction programmes for injecting drug users in Dhaka city. Harm Reduction Journal. 2005;2:22
  5. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Social Science & Medicine. 2000;51:1771–1782
  6. Bluthenthal, R. N., Anderson, R., Flynn, N. M. & Kral, A. (2006). Syringe coverage as a predictor of HIV risk among syringe exchange program clients, under review.
  7. Bluthenthal RN, Malik R, Grau LE, Singer M, Marshall PA, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004;99:1136–1146
  8. Bluthenthal, R. N., Ridgeway. G., Schell, T., Anderson, R., Flynn, N. M., & Kral, A. (in press). Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction.
  9. Brandt AM, Rozin P. Morality and health. NYC: Routledge; 1997;
  10. Burrows, D. (2001). A best practice model of harm reduction in the community and in prisons in Russian Federation final project report health nutrition and population discussion paper. Washington: World Bank.
  11. Burrows D. High coverage of harm reduction services among IDUs: Selected results and ways of measuring coverage. In: Paper presented at UN expert group meeting on measuring and increasing coverage of HIV/AIDS prevention and care services for injecting drug users, 1–2 November. Vienna. 2005;
  12. Burrows D. Advocacy and coverage of needle exchange programs: Results of a comparative study of harm reduction programs in Brazil, Bangladesh, Belarus, Ukraine, Russian Federation and China. Cadernos de Saude Publica (Reports in Public Health). April 2006;22(4):871–879
  13. Burrows D. Rethinking coverage of needle exchange programs. Substance Use and Misuse. 2006;
  14. de la Fuente L, Bravo MJ, Toro C, Brugal MT, Barrio G, Soriano V, et al. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. Journal of Epidemiology and Community Health. 2006;60:537–542
  15. Des Jarlais DC, Braine N. Assessing syringe exchange programs. Addiction. 2004;99(9):1081–1082
  16. Des Jarlais DC, Friedman SR. Fifteen years of preventing HIV infection among injection drug users: What we have learned, what we have not learned, what we have done, what we have not done. Public Health Reports. 1998;113:182–188
  17. Des Jarlais DC, Friedman SR, Burrows D. Coverage of harm reduction programs. In: Proceedings of the APMG Satellite Session on coverage of harm reduction programs at the 17th international conference on the reduction of drug-related harm, Vancouver, 2 May. Sydney/Geneva. 2006;
  18. Des Jarlais, D. C., Friedman, S. R., Burrows, D. Experts’ estimations of coverage needed for interventions to control HIV transmission among injecting drug users, in preparation.
  19. Fairbrother G, Freed GL, Thompson JW. Measuring immunization coverage. American Journal of Preventive Medicine. October 2000;19(3 suppl):78–88
  20. Gray R. Scaling up in central Asia—Recent advances & some thoughts. In: Proceedings of the APMG Satellite Session on coverage of harm reduction programs at the 17th international conference on the reduction of drug-related harm, Vancouver 2 May. Sydney/Geneva. 2006;
  21. Heimer R. The range of community coverage by syringe exchange programs in the United States. In: Proceedings of the APMG Satellite Session on coverage of harm reduction programs at the 17th international conference on the reduction of drug-related harm, Vancouver 2 May. Sydney/Geneva. 2006;
  22. Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe use and reuse: Effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes. 1998;18(suppl 1):S37–S44
  23. Hogarth J. Glossary of health care terminology. Copenhagen: WHO/EURO; 1975;
  24. Irwin K, Karchevsky E, Heimer R, Badrieva L. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation. Substance Use & Misuse. 2006;41:979–999
  25. Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes. 2004;37:1307–1312
  26. Kral AH, Bluthenthal RN. What is it about needle and syringe programs that make them effective for preventing HIV transmission. International Journal of Drug Policy. 2003;14:361–363
  27. Nokes DJ, Anderson RM. The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes. Epidemiology and Infection. August 1989;101(1):1–20
  28. Panda S, Kumar MS, Lokabiraman S, Jayashree K, Satagopan MC, Solomon S, et al. Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. Journal of Acquired Immune Deficiency Syndromes. 1 May 2005;39(1):9–15
  29. Peak A, Rana S, Maharjan SH, Jolley D, Crofts N. Declining risk for HIV among injecting drug users in Kathmandu Nepal: The impact of a harm-reduction programme. AIDS. 1995;9(9):1067–1070
  30. Sharma M, Panda S, Sharma U, Singh RR, Singh HN, Sharma C. Five years of needle syringe exchange in Manipur India: Programme and contextual issues. International Journal of Drug Policy. 2003;14:307–415
  31. Strathdee SA, Patrick D, Currie SL, Cornelisse PGA, Rekart LM, Michael SG, et al. Needle exchange is not enough: Lessons learnt from the Vancouver injection drug use study. AIDS. 1997;11:F59–F65
  32. Strathdee SA, Vlahov D. Effectiveness of needle exchange programs: A review of science and policy. AIDScience. 13 December 2001;1(16):
  33. UNAIDS. Strategy meeting to better coordinate regional support for national responses to HIV/AIDS in Eastern & Central Europe, Geneva, Palais des Nations, 4–5 November 1999.
  34. UNAIDS. High coverage sites: HIV prevention among injecting drug users in transitional and developing countries case studies. Geneva, 2006.
  35. Vickerman P, Hickman M. Measuring coverage—Model projections on the required coverage of syringe distribution to prevent HIV among injecting drug users. In: Proceedings of the APMG Satellite Session on coverage of harm reduction programs at the 17th international conference on the reduction of drug-related harm, Vancouver 2 May. Sydney/Geneva. 2006;
  36. Vickerman P, Hickman M, Rhodes T, Watts C. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. Journal of Acquired Immune Deficiency Syndromes. 2006;42(3):355–361
  37. Vickerman P, Watts C. The impact of an HIV prevention intervention for injecting drug users in Svetlogorsk, Belarus: Model predictions. The International Journal of Drug Policy. 2002;13(3):149–164
  38. Vickerman P, Watts C. Injecting drug use and the sexual transmission of HIV: Simple model insights. International Journal of Drug Policy. 2003;14:89–93
  39. WHO. Starting and managing needle-syringe programmes. Geneva, in preparation.
  40. WHO/World Bank/UNICEF/UNAIDS/Office of US Global AIDS Coordinator/USAID/CDC/The Global Fund to fight AIDS, Malaria and Tuberculosis/MEASURE Evaluation. (2006). Monitoring and evaluation toolkit: HIV/AIDS, tuberculosis and malaria (2nd ed.). Geneva: GFATM.
  41. WHO. (2001). Background paper for the technical consultation on effective coverage of health systems, 27–29 August 2001, Rio de Janeiro, Brazil. Web accessed on 16 January 2006, http://www.who.int/health-systems-performance/technical_consultations/effcov_background.pdf.
  42. Wu Z. Methadone maintenance program in mainland China: From pilot to scale-up. In: Paper presented at the 16th international conference on the reduction of drug-related harm, 20–24 March. Belfast. 2005;
  43. Zheluk A, Burrows D. A spectrum of services approach. In: Proceedings of the APMG Satellite Session on coverage of harm reduction programs at the 17th international conference on the reduction of drug-related harm, Vancouver 2 May. Sydney/Geneva. 2006;

PII: S0955-3959(06)00240-4

doi: 10.1016/j.drugpo.2006.11.012

International Journal of Drug Policy
Volume 18, Issue 2 , Pages 92-98 , March 2007

Article Tools